ArticleHeliyon2024

Transcriptome analysis reveals PRKCA as a potential therapeutic target for overcoming cisplatin resistance in lung cancer through ferroptosis.

Ting Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.